Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Forsteo 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BBABAC
|
Forsteo | Teriparatide | Endocrine System | 49 |
|
Teriparatide 20microg/80microL dose inj 2.4ml pf dispos dev
0606010U0AAACAC
|
Teriparatide | Teriparatide | Endocrine System | 11 |
|
Teriparatide 20micrograms/80microlitres dose inj 2.4ml cart
0606010U0AAAEAE
|
Teriparatide | Teriparatide | Endocrine System | 6 |
|
Movymia 20microg/80microlitres dose inj 2.4ml cart with pen
0606010U0BDAAAD
|
Movymia | Teriparatide | Endocrine System | 2 |
|
Movymia 20micrograms/80microlitres dose inj 2.4ml cartridge
0606010U0BDABAE
|
Movymia | Teriparatide | Endocrine System | 1 |
|
Terrosa 20microg/80microlitres dose inj 2.4ml cart with pen
0606010U0BEABAD
|
Terrosa | Teriparatide | Endocrine System | 1 |
|
Forsteo 20micrograms/80microlitres inj 3ml pf dispos dev
0606010U0BBAAAA
|
Forsteo | Teriparatide | Endocrine System | No data available |
|
Lusama 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BGAAAC
|
Lusama | Teriparatide | Endocrine System | No data available |
|
Sondelbay 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BFAAAC
|
Sondelbay | Teriparatide | Endocrine System | No data available |
|
Teriparatide 20microg/80microL dose inj 2.4ml cart with dev
0606010U0AAADAD
|
Teriparatide | Teriparatide | Endocrine System | No data available |
|
Teriparatide 750micrograms/3ml inj pf dispos dev
0606010U0AAAAAA
|
Teriparatide | Teriparatide | Endocrine System | No data available |
|
Terrosa 20micrograms/80microlitres dose inj 2.4ml cartridge
0606010U0BEAAAE
|
Terrosa | Teriparatide | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.